Si-Bone Inc (SIBN) - Total Assets
Based on the latest financial reports, Si-Bone Inc (SIBN) holds total assets worth $242.72 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check SIBN total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Si-Bone Inc - Total Assets Trend (2013–2025)
This chart illustrates how Si-Bone Inc's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Si-Bone Inc to see how much of total assets are deployed in long-term investments.
Si-Bone Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Si-Bone Inc's total assets of $242.72 Million consist of 90.6% current assets and 9.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.7% |
| Accounts Receivable | $29.91 Million | 12.5% |
| Inventory | $33.90 Million | 14.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Si-Bone Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SIBN company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Si-Bone Inc's current assets represent 90.6% of total assets in 2025, a decrease from 91.4% in 2013.
- Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, down from 47.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 14.2% of total assets.
Si-Bone Inc Competitors by Total Assets
Key competitors of Si-Bone Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Si-Bone Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.99 | 8.53 | 15.77 |
| Quick Ratio | 8.34 | 7.26 | 15.13 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $193.23 Million | $180.25 Million | $186.49 Million |
Si-Bone Inc - Advanced Valuation Insights
This section examines the relationship between Si-Bone Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.06 |
| Latest Market Cap to Assets Ratio | 2.15 |
| Asset Growth Rate (YoY) | 3.5% |
| Total Assets | $238.56 Million |
| Market Capitalization | $513.67 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Si-Bone Inc's assets at a significant premium (2.15x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Si-Bone Inc's assets grew by 3.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Si-Bone Inc (2013–2025)
The table below shows the annual total assets of Si-Bone Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $238.56 Million | +3.52% |
| 2024-12-31 | $230.44 Million | +0.01% |
| 2023-12-31 | $230.43 Million | +46.25% |
| 2022-12-31 | $157.55 Million | -17.30% |
| 2021-12-31 | $190.51 Million | -14.63% |
| 2020-12-31 | $223.14 Million | +90.70% |
| 2019-12-31 | $117.01 Million | -15.53% |
| 2018-12-31 | $138.52 Million | +286.56% |
| 2017-12-31 | $35.83 Million | -9.13% |
| 2016-12-31 | $39.44 Million | +9.38% |
| 2015-12-31 | $36.05 Million | +24.39% |
| 2014-12-31 | $28.98 Million | +60.90% |
| 2013-12-31 | $18.01 Million | -- |
About Si-Bone Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more